Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0360220160570030468
Journal of the Korean Ophthalmological Society
2016 Volume.57 No. 3 p.468 ~ p.476
Ahmed Valve Implant Surgery with Adjunctive Mitomycin C and Selective 5-Fluorouracil Injection
À±Àϼ®:Yun Il-Suk
ÀÌÁ¤µ¿:Lee Jung-Dong/±è¿ëÇö:Kim Yong-Hyun/¾ÈÀçÈ«:Ahn Jae-Hong
Abstract
Purpose: To evaluate the surgical results of Ahmed valve implant surgery with adjunctive mitomycin C and selective postoperative 5-fluorouracil (5-FU) subconjunctival injection with a needling procedure.

Methods: In this retrospective study, 40 eyes of 40 patients who had undergone Ahmed valve implant surgery with adjunctive mitomycin C were observed for at least 1 year. The Ahmed valve was implanted after 5-minute application of 0.04% mitomycin C. Selective 5-FU injection with a needling procedure was performed during the follow- up period based on intraocular pressure (IOP). Hypertensive phase was defined as IOP higher than 21 mm Hg within 3 months after operation. IOP higher than 18 mm Hg regardless of IOP-lowering medications at 2 consecutive visits was considered to be a surgical failure.

Results: The mean follow-up period was 35.5 ¡¾ 12.4 months. Preoperative intraocular pressure was 32.8 ¡¾ 7.5 mm Hg, which decreased to 14.0 ¡¾ 4.2 mm Hg postoperatively. The number of glaucoma medications decreased significantly from 3.8 ¡¾ 0.5 to 2.0 ¡¾ 1.0. Eleven of 40 eyes (27.5%) experienced hypertensive phase at 6.0 ¡¾ 3.1 weeks after surgery. Kaplan-Meier survival analysis showed cumulative probability of surgical success rates of 82.5%, 79.6%, 72.7%, and 58.8% at 1, 2, 3, and 4 postoperative years respectively. There were no risk factors that affecting surgical failure except age (hazard ratio = 0.17, p = 0.02).

Conclusions: Ahmed valve implant surgery with adjunctive mitomycin C and selective 5-FU injection with a needling procedure showed good success in refractory glaucoma.
KEYWORD
Ahmed valve implant, 5-Fluorouracil, Mitomycin C, Needling, Refractory glaucoma
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø